Leaflet VALEPIL 200mg / 5ml syrup


Indicated for: epilepsy; bipolar disorder

Substance: valproic acid + salts (antiepileptics)

ATC: N03AG01 (Nervous system | Antiepileptics | Fatty acid derivatives)

Valproic acid and its salts (e.g., sodium valproate) are used to treat epilepsy, bipolar disorder, and prevent migraines. They stabilize brain electrical activity, preventing seizures and episodes of mania or depression.

Valproic acid increases GABA (gamma-aminobutyric acid) levels, an inhibitory neurotransmitter, reducing neuronal excitability. It is indicated for generalized and focal epilepsy, bipolar disorder, and migraine prevention.

Side effects may include nausea, drowsiness, weight gain, or tremor. Rarely, it can affect the liver or pancreas. It is contraindicated during pregnancy due to the risk of congenital malformations. Treatment must be monitored by a doctor.

General data about VALEPIL 200mg / 5ml

  • Substance: valproic acid + salts
  • Date of last drug list: 01-09-2024
  • Commercial code: W43170001
  • Concentration: 200mg / 5ml
  • Pharmaceutical form: syrup
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: MEDUMAN SA - ROMANIA
  • Holder: ARENA GROUP S.A. - ROMANIA
  • Number: 9063/2016/01
  • Shelf life: 2 years

Concentrations available for valproic acid + salts

  • 1000mg
  • 100mg
  • 150mg
  • 200mg
  • 200mg/5ml
  • 250mg
  • 300mg
  • 300mg/5ml
  • 400mg/4ml
  • 500mg
  • 50mg/ml
  • 57.64mg/ml
  • 600mg
  • 750mg